{
  "id": "5713c4a11174fb1755000013",
  "type": "yesno",
  "question": "Is glycyl-tRNA synthetase gene involved in the development of Charcot-Marie-Tooth disease?",
  "ideal_answer": "Dominant mutations in GARS, encoding the essential enzyme glycyl-tRNA synthetase (GlyRS), result in a form of Charcot-Marie-Tooth disease, type 2D (CMT2D), predominantly characterized by lower motor nerve degeneration.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/17035524",
    "http://www.ncbi.nlm.nih.gov/pubmed/25420567",
    "http://www.ncbi.nlm.nih.gov/pubmed/16982418",
    "http://www.ncbi.nlm.nih.gov/pubmed/12690580",
    "http://www.ncbi.nlm.nih.gov/pubmed/24669931",
    "http://www.ncbi.nlm.nih.gov/pubmed/24368416",
    "http://www.ncbi.nlm.nih.gov/pubmed/25168514",
    "http://www.ncbi.nlm.nih.gov/pubmed/17545306",
    "http://www.ncbi.nlm.nih.gov/pubmed/23279345",
    "http://www.ncbi.nlm.nih.gov/pubmed/23990368",
    "http://www.ncbi.nlm.nih.gov/pubmed/22144914",
    "http://www.ncbi.nlm.nih.gov/pubmed/24898252",
    "http://www.ncbi.nlm.nih.gov/pubmed/19470612"
  ],
  "snippets": [
    {
      "text": "Charcot-Marie-Tooth disease type 2D (CMT2D) is an autosomal-dominant axonal peripheral neuropathy characterized by impaired motor and sensory function in the distal extremities. Mutations in the glycyl-tRNA synthetase (GARS) gene cause CMT2D",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25168514",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Dominant mutations in GARS cause rare forms of Charcot-Marie-Tooth disease and distal spinal muscular atrophy",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24669931",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Using exome sequencing she was found to harbor compound heterozygous mutations within the glycyl-tRNA synthetase (GARS) gene",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24669931",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "mutations of human GlyRS (hGlyRS) were also found to be associated with Charcot-Marie-Tooth disease",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24898252",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Dominant mutations in GARS, encoding the essential enzyme glycyl-tRNA synthetase (GlyRS), result in a form of Charcot-Marie-Tooth disease, type 2D (CMT2D), predominantly characterized by lower motor nerve degeneration",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24368416",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A novel mutation in glycyl-tRNA synthetase caused Charcot-Marie-Tooth disease type 2D with facial and respiratory muscle involvement",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25420567",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Here we describe a 45-year-old woman with a long course of motor-dominant neuropathy. Distal weakness appeared in childhood and became worse with age. After a diagnosis of CMT type 2, the symptoms progressed, and in her fourth decade, facial and respiratory muscle weakness appeared, ultimately requiring non-invasive mechanical ventilation. There was no family history of CMT. Comprehensive analysis of known CMT-related genes revealed a novel heterozygous c.815T>A, p.L218Q mutation in glycyl-tRNA synthetase (GARS), a causative gene for both CMT type 2D (CMT2D) and distal spinal muscular atrophy type V (dSMA-V)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25420567",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Charcot-Marie-Tooth disease type 2D (CMT2D) is a dominantly inherited peripheral neuropathy caused by missense mutations in the glycyl-tRNA synthetase gene (GARS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22144914",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Long-range structural effects of a Charcot-Marie-Tooth disease-causing mutation in human glycyl-tRNA synthetase.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17545306",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12690580",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "[A novel mutation in glycyl-tRNA synthetase caused Charcot-Marie-Tooth disease type 2D with facial and respiratory muscle involvement].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25420567",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Glycyl-tRNA synthetase (GARS), which encodes the enzyme responsible for charging tRNA(Gly) with glycine in both the cytoplasm and mitochondria, is implicated to Charcot-Marie-Tooth disease 2D (CMT2D) and distal hereditary motor neuropathy type V (dHMN-V).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23279345",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These additional functions may explain why dominant mutations in glycyl-tRNA synthetase (GlyRS) and tyrosyl-tRNA synthetase cause Charcot-Marie-Tooth (CMT) disease, the most common heritable disease of the peripheral nervous system.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17545306",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here, we report the identification of four disease-associated missense mutations in the glycyl tRNA synthetase gene in families with CMT2D and dSMA-V.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12690580",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mutations in the glycyl-tRNA synthetase (GARS) gene cause CMT2D.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25168514",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Of the many inherited Charcot-Marie-Tooth peripheral neuropathies, type 2D (CMT2D) is caused by dominant point mutations in the gene GARS, encoding glycyl tRNA synthetase (GlyRS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16982418",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Charcot-Marie-Tooth disease type 2D (CMT2D) is a dominantly inherited peripheral neuropathy caused by missense mutations in the glycyl-tRNA synthetase gene (GARS)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22144914",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Charcot-Marie-Tooth disease type 2D is a hereditary axonal and glycyl-tRNA synthetase (GARS)-associated neuropathy that is caused by a mutation in GARS",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990368",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Long-range structural effects of a Charcot-Marie-Tooth disease-causing mutation in human glycyl-tRNA synthetase",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17545306",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "These additional functions may explain why dominant mutations in glycyl-tRNA synthetase (GlyRS) and tyrosyl-tRNA synthetase cause Charcot-Marie-Tooth (CMT) disease, the most common heritable disease of the peripheral nervous system",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17545306",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A novel mutation in glycyl-tRNA synthetase caused Charcot-Marie-Tooth disease type 2D with facial and respiratory muscle involvement.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25420567",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Charcot-Marie-Tooth disease type 2D (CMT2D) is a dominantly inherited peripheral neuropathy caused by missense mutations in the glycyl-tRNA synthetase gene (GARS). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22144914",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mutations in the glycyl-tRNA synthetase (GARS) gene cause CMT2D. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25168514",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19470612",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We previously implicated mutations in the gene encoding glycyl-tRNA synthetase (GARS) as the cause of CMT2D and dSMA-V. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17035524",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16982418",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Charcot-Marie-Tooth disease type 2D is a hereditary axonal and glycyl-tRNA synthetase (GARS)-associated neuropathy that is caused by a mutation in GARS. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990368",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Dominant mutations in GARS, encoding the essential enzyme glycyl-tRNA synthetase (GlyRS), result in a form of Charcot-Marie-Tooth disease, type 2D (CMT2D), predominantly characterized by lower motor nerve degeneration. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24368416",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Charcot-Marie-Tooth disease type 2D (CMT2D) is a dominantly inherited peripheral neuropathy caused by missense mutations in the glycyl-tRNA synthetase gene (GARS). In addition to GARS, mutations in three other tRNA synthetase genes cause similar neuropathies, although the underlying mechanisms are not fully understood.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22144914",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These additional functions may explain why dominant mutations in glycyl-tRNA synthetase (GlyRS) and tyrosyl-tRNA synthetase cause Charcot-Marie-Tooth (CMT) disease,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17545306",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Charcot-Marie-Tooth disease type 2D (CMT2D) is an autosomal-dominant axonal peripheral neuropathy characterized by impaired motor and sensory function in the distal extremities. Mutations in the glycyl-tRNA synthetase (GARS) gene cause CMT2D.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25168514",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Of the many inherited Charcot-Marie-Tooth peripheral neuropathies, type 2D (CMT2D) is caused by dominant point mutations in the gene GARS, encoding glycyl tRNA synthetase (GlyRS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16982418",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Charcot-Marie-Tooth disease type 2D (CMT2D) is a dominantly inherited peripheral neuropathy caused by missense mutations in the glycyl-tRNA synthetase gene (GARS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22144914",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Long-range structural effects of a Charcot-Marie-Tooth disease-causing mutation in human glycyl-tRNA synthetase.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17545306",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12690580",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "These additional functions may explain why dominant mutations in glycyl-tRNA synthetase (GlyRS) and tyrosyl-tRNA synthetase cause Charcot-Marie-Tooth (CMT) disease, the most common heritable disease of the peripheral nervous system.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17545306",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A novel mutation in glycyl-tRNA synthetase caused Charcot-Marie-Tooth disease type 2D with facial and respiratory muscle involvement.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25420567",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16982418",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Glycyl-tRNA synthetase (GARS), which encodes the enzyme responsible for charging tRNA(Gly) with glycine in both the cytoplasm and mitochondria, is implicated to Charcot-Marie-Tooth disease 2D (CMT2D) and distal hereditary motor neuropathy type V (dHMN-V).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23279345",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}